+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07777367

Exercise Performance Comparison Between Ambient Air and Nasal Low-Flow Oxygen Therapy in Patients with Exercise-Induced Desaturation Due to Pulmonary Vascular Disease

Led by Silvia Ulrich Somaini · Updated on 2026-09-09

40

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the impact of liquid oxygen therapy delivered via nasal cannula at approximately 4 liters per minute on exercise performance in Swiss residents with pulmonary vascular diseases. These diseases include pulmonary arterial hypertension PAH and chronic thromboembolic pulmonary hypertension CTEPH. The study aims to compare the distance walked in 6 minutes 6MWD with and without supplemental liquid oxygen therapy in the same participants. Participants diagnosed with precapillary pulmonary hypertension through right heart catheterization and classified as PAH or CTEPH will undergo a 6-minute walk test twice. One walk will be performed under normal ambient air conditions, and the other with supplemental liquid oxygen therapy at about 4 liters per minute delivered through a nasal cannula. This comparison follows a randomized crossover design, meaning each participant experiences both conditions in a random order. During the study, participants will be assessed at the University Hospital Zurich where clinical evaluations will be conducted. Researchers will measure the distance covered in the 6-minute walk test, oxygen saturation SpO2, heart rate, blood pressure, and ratings of breathlessness and leg fatigue both at rest and at the peak of walking, comparing results with and without oxygen therapy. The study is scheduled to continue until the end of 2028, with participant involvement including the two walk tests and associated monitoring during these assessments.

CONDITIONS

Brief Title

Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases

Research Team

S

Silvia Ulrich, Prof. Dr. med.

M

Mona Lichtblau, PD. Dr. med.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here